Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2509-4254
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia ; volume:6 ; number:6 ; day:9 ; month:8 ; year:2022 ; pages:837-846 ; date:11.2022
PharmacoEconomics - open ; 6, Heft 6 (9.8.2022), 837-846, 11.2022
- Creator
-
Gil, Fabio
Juliao-Baños, Fabian
Amador, Luisa
Castano, Natalia
Reyes, Juan Manuel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-022-00360-4
- URN
-
urn:nbn:de:101:1-2023011021051972076701
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gil, Fabio
- Juliao-Baños, Fabian
- Amador, Luisa
- Castano, Natalia
- Reyes, Juan Manuel
- SpringerLink (Online service)
Other Objects (12)
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib in treatment-refractory moderate to severe ulcerative colitis: real-world experience from a retrospective multicenter observational study
Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib in treatment-refractory moderate to severe ulcerative colitis: real-world experience from a retrospective multicenter observational study
Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib in treatment-refractory moderate to severe ulcerative colitis: real-world experience from a retrospective multicenter observational study
Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa